Perani Laura L - OmicsDI

Show results for

Metabolomics (2)
Transcriptomics (1)

Organisms

Homo sapiens (1)

Repository

MetaboLights (2)
biostudies-arrayexpress (1)

Technology Type

Mass spectrometry (2)

Instrument Platform

Q Exactive (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2022 (2)
2012 (1)

CHEBI ID

CHEBI:16628 (2)
CHEBI:17768 (2)
CHEBI:58148 (2)
CHEBI:70959 (2)
CHEBI:24149 (2)
CHEBI:89461 (2)
CHEBI:35704 (2)
CHEBI:17713 (2)
CHEBI:17172 (2)
CHEBI:16450 (2)
CHEBI:16675 (2)
CHEBI:28747 (2)
CHEBI:50129 (2)
CHEBI:60175 (2)
CHEBI:15611 (2)
CHEBI:17287 (2)
CHEBI:49033 (2)
CHEBI:15978 (2)
CHEBI:17677 (2)
CHEBI:184023 (2)
CHEBI:48928 (2)
CHEBI:17050 (2)
CHEBI:18295 (2)
CHEBI:18257 (2)
CHEBI:43580 (2)
CHEBI:15698 (2)
CHEBI:17140 (2)
CHEBI:17533 (2)
CHEBI:16708 (2)
CHEBI:17724 (2)

Metabolite Name

O-Tyrosine (2)
D-Alpha-aminobutyric acid (1)
Iodotyrosine (1)
All-trans-retinoic acid (1)
D-threo-Isocitric acid (1)
Methylglutaric acid (1)
Alpha-Hydroxyisobutyric acid (1)
Guanosine diphosphate (1)
3-Phosphoglyceric acid (1)
4-chlorobenzoic acid (1)
2-hydroxy-4-(methylthio)butanoic acid (1)
Isoleucylhydroxyproline* (1)
Leucylhydroxyproline* (1)
N-carboxymethylalanine (1)
3-hydroxydecanoylcarnitine (1)
S-(1,2-dicarboxyethyl)glutathione (1)
N-acetyl-isoputreanine (1)
N6,N6-dimethyllysine (1)
Ascorbic acid 3-sulfate* (1)
N,N-dimethylalanine (1)
3-amino-2-piperidone (1)
3-formylindole (1)
Hydroxyasparagine** (1)
Lyxonate (1)
N-stearoylserine* (1)
3-hydroxyoleoylcarnitine (1)
3-hydroxypalmitoylcarnitine (1)
2-butenoylglycine (1)
Palmitoleoyl ethanolamide* (1)
Sphingomyelin (d18:2/18:1)* (1)

Study type

Transcription profiling by array (1)

Release Date

2012 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Xenograft assays)

Glioblastoma (GBM) is a common and deadly form of brain tumor in adults. Dysregulated metabolism in GBM offers an opportunity to deploy metabolic interventions as precise therapeutic strategies. To identify the molecular drivers and the modalities by which different molecular subgroups of GBM exp...

2022-11-08 | MTBLS730 | MetaboLights

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Stem cell and cell line assays)

2022-11-08 | MTBLS4708 | MetaboLights

Gene expression profile of human iPS cell-derived mesoangioblasts (HIDEMs)

Mesoangioblasts are stem/progenitor cells derived from a subset of pericytes expressing alkaline phosphatase. They have been shown to ameliorate muscular dystrophies (currently incurable diseases) in different animal models and are now undergoing clinical experimentation for Duchenne muscular dystro...

ORGANISM(S): Homo sapiens

2012-07-08 | E-GEOD-36098 | biostudies-arrayexpress

Previous page
1 / 1
You're on page 1
Next page